Historical salary details - Mr. James H. Quigley, Chairman of the Board, Hess Corporation
Mr. James H. Quigley is the Chairman of the Board of Hess Corporation.
Mr. James H. Quigley
Chairman of the Board
$ 563.5 K
Gross Remuneration
-
Current Company
Hess Corporation
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Hess Corporation | Chairman of the Board | 563.5 K | -0.0 % |
| 2023 | Hess Corporation | Chairman of the Board | 563.5 K | 9.7 % |
| 2022 | Hess Corporation | Chairman of the Board | 513.6 K | 0.2 % |
| 2021 | Hess Corporation | Chairman of the Board | 512.6 K | 2.1 % |
| 2020 | Hess Corporation | Chairman of the Board | 502.0 K | 2.6 % |
| 2020 | Wells Fargo & Co. | - | 55.2 K | -87.0 % |
| 2020 | Wells Fargo & Co. | Independent Director | - | - |
| 2019 | Hess Corporation | Chairman of the Board | 489.1 K | -3.7 % |
| 2019 | Wells Fargo & Co. | Independent Director | 425.0 K | 1.9 % |
| 2019 | Merrimack Pharmaceuticals Inc | - | 50.4 K | -52.2 % |
| 2019 | Merrimack Pharmaceuticals Inc | Independent Director | - | - |
| 2018 | Hess Corporation | Chairman of the Board | 508.0 K | 0.2 % |
| 2018 | Wells Fargo & Co. | Independent Director | 417.0 K | -1.9 % |
| 2018 | Merrimack Pharmaceuticals Inc | Independent Director | 105.6 K | -16.2 % |
| 2017 | Hess Corporation | Chairman of the Board | 506.8 K | 5.0 % |
| 2017 | Wells Fargo & Co. | Independent Director | 425.0 K | -0.9 % |
| 2017 | Merrimack Pharmaceuticals Inc | Independent Director | 126.0 K | -42.8 % |
| 2016 | Hess Corporation | Chairman of the Board | 482.7 K | 37.5 % |
| 2016 | Wells Fargo & Co. | Independent Director | 429.0 K | 12.3 % |
| 2016 | Merrimack Pharmaceuticals Inc | Independent Director | 220.1 K | 38.3 % |
| 2015 | Wells Fargo & Co. | Independent Director | 382.0 K | 23.0 % |
| 2015 | Hess Corporation | Independent Director | 351.0 K | 0.1 % |
| 2015 | Merrimack Pharmaceuticals Inc | Independent Director | 159.2 K | -4.6 % |
| 2014 | Hess Corporation | Independent Director | 350.8 K | 18.9 % |
| 2014 | Wells Fargo & Co. | Independent Director | 310.5 K | 171.8 % |
| 2014 | Merrimack Pharmaceuticals Inc | Independent Director | 166.9 K | 14.6 % |
| 2013 | Hess Corporation | Independent Director | 294.9 K | - |
| 2013 | Merrimack Pharmaceuticals Inc | Independent Director | 145.6 K | 24.6 % |
| 2013 | Wells Fargo & Co. | Independent Director | 114.3 K | - |
| 2012 | Merrimack Pharmaceuticals Inc | Independent Director | 116.9 K | - |
| 2012 | Hess Corporation | Independent Director | - | - |